NIAID Banner Logo Image

ONLINE DATABASE SEARCH - OI-LS-313-MEMO

1. 44662 OI-LS-313; PUBMED-OI-1/11/2004

Clinical utility of antifungal pharmacokinetics and pharmacodynamics

Andes, D

Curr Opin Infect Dis 2004. 17(6): 533-40


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15640707&dopt=abstract


2. 44663 OI-LS-313; PUBMED-OI-1/11/2004

Antitubercular activity of triterpenoids from asteraceae flowers

Akihisa, T, Franzblau, SG, Ukiya, M, Okuda, H, Zhang, F, Yasukawa, K, Suzuki, T, and Kimura, Y

Biol Pharm Bull 2005. 28(1): 158-60


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15635183&dopt=abstract


3. 44664 OI-LS-313; PUBMED-OI-1/11/2004

IFN-{alpha}{beta} Secreted during Infection Is Necessary but Not Sufficient for Negative Feedback Regulation of IFN-{alpha}{beta} Signaling by Mycobacterium tuberculosis

Prabhakar, S, Qiao, Y, Canova, A, Tse, DB, and Pine, R

J Immunol 2005. 174(2): 1003-1012


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15634924&dopt=abstract


4. 44665 OI-LS-313; PUBMED-OI-1/11/2004

Evaluation of Mycograb(R), amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies

Nooney, L, Matthews, RC, and Burnie, JP

Diagn Microbiol Infect Dis 2005. 51(1): 19-29


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15629225&dopt=abstract


5. 44666 OI-LS-313; PUBMED-OI-1/11/2004

The Crystal Structure of Mycobacterium tuberculosis Thymidylate Kinase in Complex with 3'-Azidodeoxythymidine Monophosphate Suggests a Mechanism for Competitive Inhibition(,)

Fioravanti, E, Adam, V, Munier-Lehmann, H, and Bourgeois, D

Biochemistry 2005. 44(1): 130-137


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15628853&dopt=abstract



6. 44667 OI-LS-313; SCIFINDER-OI-1/5/2005

Phosphatidylinositol 3-Kinase and Frabin Mediate Cryptosporidium parvum Cellular Invasion via Activation of Cdc42

Chen, Xian-Ming, Splinter, Patrick L, Tietz, Pamela S, Huang, Bing Q, Billadeau, Daniel D, and LaRusso, Nicholas F

Journal of Biological Chemistry 2004. 279(30): 31671-31678


7. 44668 OI-LS-313; PUBMED-OI-1/11/2004

Further Acquisition of Drug-Resistance in Multidrug-Resistant Tuberculosis during Chemotherapy

Toyota, E, Sekiguchi, J, Shimizu, H, Fujino, T, Otsuka, Y, Yoshikura, H, Kuratsuji, T, Kirikae, T, and Kudo, K

Jpn J Infect Dis 2004. 57(6): 292-4


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15623961&dopt=abstract


8. 44669 OI-LS-313; PUBMED-OI-1/11/2004

Antimycobacterial Compounds from Piper sanctum

Mata, R, Morales, I, Perez, O, Rivero-Cruz, I, Acevedo, L, Enriquez-Mendoza, I, Bye, R, Franzblau, S, and Timmermann, B

J Nat Prod 2004. 67(12): 1961-1968


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15620234&dopt=abstract


9. 44670 OI-LS-313; SCIFINDER-OI-1/5/2005

In vitro activity on Cryptosporidium parvum oocyst of different drugs with recognized anticryptosporidial efficacy

Castro-Hermida, JA, Pors, I, Ares-Mazas, E, and Chartier, C

Revue de Medecine Veterinaire (Toulouse, France) 2004. 155(8-9): 453-456


10. 44671 OI-LS-313; SCIFINDER-OI-1/5/2005

In Vitro Antibacterial and Antifungal Activities of Extracts and Compounds from Uvaria scheffleri

Moshi, Mainen, Joseph, Cosam, Innocent, Esther, and Nkunya, Mayunga

Pharmaceutical Biology (Lisse, Netherlands) 2004. 42(4-5): 269-273


11. 44672 OI-LS-313; SCIFINDER-OI-1/5/2005

Synthesis and potent antimicrobial activity of some novel 4-(5,6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides

Oezden, Seckin, Karatas, Hacer, Yildiz, Sulhiye, and Goeker, Hakan

Archiv der Pharmazie (Weinheim, Germany) 2004. 337(10): 556-562



12. 44673 OI-LS-313; PUBMED-OI-1/11/2004

The past, present and future of antiviral drug discovery

Littler, E

IDrugs 2004. 7(12): 1104-12


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15599804&dopt=abstract


13. 44674 OI-LS-313; SCIFINDER-OI-1/5/2005

Synthesis and microbiological activity of some substituted N-(2-hydroxy-4-nitrophenyl)benzamides and phenylacetamides as possible metabolites of antimicrobial active benzoxazoles

Oeren, Ilkay Yildiz, Aki-Sener, Esin, Ertas, Cengiz, Arpaci, Oezlem Temiz, Yalcin, Ismail, and Altanlar, Nurten

Turkish Journal of Chemistry 2004. 28(4): 441-449


14. 44675 OI-LS-313; PUBMED-OI-1/11/2004

Inhibitors of virus replication: recent developments and prospects

Magden, J, Kaariainen, L, and Ahola, T

Appl Microbiol Biotechnol 2004.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15592828&dopt=abstract


15. 44676 OI-LS-313; SCIFINDER-OI-1/5/2005

Synthesis and antifungal activity of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(4-substituted acyl piperazin-1-yl)-2-propanols

Liang, Shuang, Liu, Chao-mei, Zhu, Jie, He, Qiu-qin, Jiang, Yuan-ying, and Cao, Yong-bing

Journal of Medical Colleges of PLA 2004. 19(3): 142-145


16. 44677 OI-LS-313; SCIFINDER-OI-1/5/2005

Isatin-derived Antibacterial and Antifungal Compounds and their Transition Metal Complexes

Chohan, Zahid H, Pervez, Humayun, Rauf, A, Khan, Khalid M, and Supuran, Claudiu T

Journal of Enzyme Inhibition and Medicinal Chemistry 2004. 19(5): 417-423


17. 44678 OI-LS-313; SCIFINDER-OI-1/5/2005

In vitro anti-candidal activity of the essential oil of Illicium verum

Zhao, Junli, Luo, Zhicheng, Wu, Sanmao, Zhou, Xiaoli, Xue, Xiaoyun, Shi, Lei, and Li, Wenzhu

Zhonghua Pifuke Zazhi 2004. 37(8): 475-477


18. 44679 OI-LS-313; SCIFINDER-OI-1/5/2005

Synthesis and antifungal activity of cholesterol-hydrazone derivatives

Loncle, Celine, Brunel, Jean Michel, Vidal, Nicolas, Dherbomez, Michel, and Letourneux, Yves

European Journal of Medicinal Chemistry 2004. 39(12): 1067-1071



19. 44680 OI-LS-313; SCIFINDER-OI-1/5/2005

Preparation of 3-deoxyanthocyanidine compounds and their use as antimicrobial agents

George, Florian and Fellague, Toufik

PATENT: FR 2855172 ISSUE DATE: 20041126

APPLICATION: 2003-6088 PP: 60 pp.

ASSIGNEE: (Synth'e 163, Fr.


20. 44681 OI-LS-313; WOS-OI-1/2/2005

Albuferon (TM) - A novel therapeutic agent for hepatitis C: Results of a phase 1/2 study in treatment experienced subjects with chronic hepatitis C

Balan, V, Sulkowski, M, Nelson, D, Everson, G, Lambiase, L, Post, A, Redfield, R, Wiesner, R, Davis, G, Neumann, A, Recta, J, Moore, P, Osborn, B, Novello, L, Freimuth, W, and Subramanian, M

HEPATOLOGY 2004. 40(4): 280A-281A, 2


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100267


21. 44682 OI-LS-313; SCIFINDER-OI-1/5/2005

Diastereoselective Synthesis and Antifungal Activity of Glycosyl Isoxazolines

Mishra, Ram Chandra, Tewari, Neetu, Verma, Shyam Sunder, Tripathi, Rama Pati, Kumar, Manish, and Shukla, Praveen Kumar

Journal of Carbohydrate Chemistry 2004. 23(6 & 7): 353-374


22. 44683 OI-LS-313; WOS-OI-1/2/2005

Final results of ANRS HC02-RIBAVIC: A randomized controlled trial of pegylated-interferon alfa-2B plus ribavirin vs interferon alfa-2B plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected

Pol, S, Carrat, F, Bani-Sadr, F, Rosenthal, E, Lunel, F, Morand, P, Salmon, D, Pialoux, G, Patrice, C, and Christian, P

HEPATOLOGY 2004. 40(4): 315A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100353


23. 44684 OI-LS-313; WOS-OI-1/2/2005

Dynamics of HCV free-virion and immunecomplex during interferon therapy with and without ribavirin in genotype-1B chronic hepatitis C

Fujita, N, Kaito, M, Takeo, M, Sugimoto, R, Horiike, S, Tanaka, H, Konishi, M, Watanabe, S, and Adachi, Y

HEPATOLOGY 2004. 40(4): 319A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100361


24. 44685 OI-LS-313; SCIFINDER-OI-1/5/2005

Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds

Cushion, Melanie T, Walzer, Peter D, Collins, Margaret S, Rebholz, Sandra, Vanden Eynde, Jean Jacques, Mayence, Annie, and Huang, Tien L

Antimicrobial Agents and Chemotherapy 2004. 48(11): 4209-4216



25. 44686 OI-LS-313; WOS-OI-1/2/2005

Molecular mechanism susceptibility profile of BILN-2061 to various hepatitis C virus genotypes and NS3-NS4A protease inhibitor mutation: D168A and D168V

Courcambeck, J, Perbost, R, Chabaud, P, Pepe, G, Bouzidi, M, Mabrouk, K, Sabatier, JM, and Halfon, P

HEPATOLOGY 2004. 40(4): 385A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100515


26. 44687 OI-LS-313; WOS-OI-1/2/2005

In vitro resistance mutations against VX-950 and BILN 2061, two HCV protease inhibitor clinical candidates: Single-resistance, cross-resistance, and fitness

Lin, C, Rao, BG, Luong, YP, Fulghum, JR, Brennan, DL, Wei, YY, Frantz, JD, Lippke, J, Hsiao, HM, Ma, S, Lin, K, Maxwell, JP, Cottrell, KM, Gates, CA, Perni, RB, and Kwong, AD

HEPATOLOGY 2004. 40(4): 404A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100554


27. 44688 OI-LS-313; WOS-OI-1/2/2005

High-throughput screening of anti-HCV drug candidates using an ELISA-based HCV replicon assay

Tan, H, Hong, J, Seiwert, S, and Blatt, LM

HEPATOLOGY 2004. 40(4): 407A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100560


28. 44689 OI-LS-313; SCIFINDER-OI-1/5/2005

Preparation of 2,4-diaminoquinazoline, 2-amino-4-hydroxypteridine and 2,4-diaminopyrimidine ester derivatives as dihydrofolate reductase inhibitors

Boman, Arne, Lundstedt, Torbjorn, Andersson, Per, and Seifert, Elisabeth

PATENT: WO 2004020417 ISSUE DATE: 20040311

APPLICATION: 2003 PP: 41 pp.

ASSIGNEE: (Melacure Therapeutics AB, Swed. and Pett, Christopher Phineas


29. 44690 OI-LS-313; SCIFINDER-OI-1/5/2005

Discovery of Bicyclic Thymidine Analogues as Selective and High-Affinity Inhibitors of Mycobacterium tuberculosis Thymidine Monophosphate Kinase

Vanheusden, Veerle, Munier-Lehmann, Helene, Froeyen, Matheus, Busson, Roger, Rozenski, Jef, Herdewijn, Piet, and Van Calenbergh, Serge

Journal of Medicinal Chemistry 2004. 47(25): 6187-6194


30. 44691 OI-LS-313; SCIFINDER-OI-1/5/2005

Few amino acid positions in are associated with most of the rifampin resistance in Mycobacterium tuberculosis

Cummings, Michael P and Segal, Mark R

BMC Bioinformatics 2004. 5: No pp. given


31. 44692 OI-LS-313; SCIFINDER-OI-1/5/2005

<04 Article Title>

Metaferia, Belhu B and Bewley, Carole A

<10 Journal Title> 2004.(<24 Issue ID>): <25 Page(s)>



32. 44693 OI-LS-313; SCIFINDER-OI-1/5/2005

Mycobacterium tuberculosis mutants with disabled Rv3351c (NecB) and Rv3874 genes as vaccines, for producing diagnostic antibodies and for screening tuberculosis inhibitors

King, CHarold, Jacobs, William, and Okenu, Daniel

PATENT: WO 2004067718 ISSUE DATE: 20040812

APPLICATION: 2004 PP: 144 pp.

ASSIGNEE: (Emory University, USA


33. 44694 OI-LS-313; WOS-OI-1/2/2005

Selection and characterization of hepatitis C virus replicons resistant to potent NS5B polymerase inhibitors

Lu, LJ, Mo, HM, Pilot-Matias, T, Dekhtyar, T, Ng, T, Pithawalla, R, Masse, S, Pratt, J, Donner, P, Maring, C, and Molla, A

HEPATOLOGY 2004. 40(4): 694A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102101219


34. 44695 OI-LS-313; SCIFINDER-OI-1/5/2005

A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential

Copenhaver, Robert H, Sepulveda, Eliud, Armitige, Lisa Y, Actor, Jeffrey K, Wanger, Audrey, Norris, Steven J, Hunter, Robert L, and Jagannath, Chinnaswamy

Infection and Immunity 2004. 72(12): 7084-7095


35. 44696 OI-LS-313; SCIFINDER-OI-1/5/2005

1,3,4-Thiadiazole Derivatives. Synthesis, Structure Elucidation, and Structure-Antituberculosis Activity Relationship Investigation

Oruc, Elcin E, Rollas, Sevim, Kandemirli, Fatma, Shvets, Nathaly, and Dimoglo, Anatholy S

Journal of Medicinal Chemistry 2004. 47(27): 6760-6767


36. 44697 OI-LS-313; WOS-OI-1/2/2005

Results of a phase I single-dose escalation study of the hepatitis C protease inhibitor VX950 in healthy volunteers

Chu, HM, McNair, L, and Purdy, S

HEPATOLOGY 2004. 40(4): 735A-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102101309


37. 44698 OI-LS-313; SCIFINDER-OI-1/5/2005

Preparation of benzimidazolyl ureas and related compounds as gyrase inhibitors for treating bacterial infections

Charifson, Paul S, Deininger, David D, Grillot, Anne-Laure, Liao, Yusheng, Ronkin, Steven M, Stamos, Dean, Perola, Emanuele, Wang, Tiansheng, Letiran, Arnaud, and Drumm, Joseph

PATENT: US 2004235886 ISSUE DATE: 20041125

APPLICATION: 2004-46742 PP: 148 pp.

ASSIGNEE: (USA)



38. 44699 OI-LS-313; SCIFINDER-OI-1/5/2005

Inhibitors of mycobacterial serine/threonine protein kinases for the treatment of mycobacterial infections

Pato, Janos, Keri, Gyorgy, Orfi, Laszlo, Waczek, Frigyes, Horvath, Zoltan, Banhegyi, Peter, Szabadkai, Istavan, Marosfalvi, Jeno, Hegymegi-Barakonyi, Balint, Szekelyhidi, Zsolt, Greff, Zoltan, Choidas, Axel, Bacher, Gerald, Missio, Andrea, and Koul, Anil

PATENT: US 2004171603 ISSUE DATE: 20040902

APPLICATION: 2003-60231 PP: 51 pp., Cont.-in-part of Appl. No. PCT/EP03-03697.

ASSIGNEE: (Hung.)


39. 44700 OI-LS-313; WOS-OI-1/2/2005

Toxicogenomics in drug discovery: from preclinical studies to clinical trials

Yang, Y, Blomme, EAG, and Waring, JF

CHEMICO-BIOLOGICAL INTERACTIONS 2004. 150(1): 71-85, 15


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225349900007


40. 44701 OI-LS-313; WOS-OI-1/2/2005

Interaction of shikimic acid with shikimate kinase

Pereira, JH, de Oliveira, JS, Canduri, F, Dias, MVB, Palma, MS, Basso, LA, de Azevedo, WF, and Santos, DS

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2004. 325(1): 10-17, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225173400003


41. 44702 OI-LS-313; WOS-OI-1/2/2005

Cell biology of Mycobacterium tuberculosis phagosome

Vergne, I, Chua, J, Singh, SB, and Deretic, V

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY 2004. 20: 367-394, 28


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225318200014


42. 44703 OI-LS-313; WOS-OI-1/9/2005

Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates

Lenaerts, AJ, Chapman, PL, and Orme, IM

TUBERCULOSIS 2004. 84(6): 361-364, 4


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225476500004


43. 44704 OI-LS-313; SCIFINDER-OI-1/5/2005

A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation

Carter, George, Young, Lowell S, and Bermudez, Luiz E

Antimicrobial Agents and Chemotherapy 2004. 48(12): 4907-4910


44. 44705 OI-LS-313; SCIFINDER-OI-1/5/2005

Heterocyclic compounds, specifically 3,6-disubstituted 3H-furo[2,3-d]pyrimidin-2-ones and 2,6-disubstituted furo[2,3-d]pyrimidines, for use as novel nucleoside analogs and antivirals in the treatment of viral infections, particularly cytomegalovirus

McGuigan, Christopher, Balzarini, Jan, and De Clercq, Erik

PATENT: WO 2004096813 ISSUE DATE: 20041111

APPLICATION: 2004 PP: 62 pp.

ASSIGNEE: (University College Cardiff Consultants Limited, UK and Rega Foundation)


45. 44706 OI-LS-313; WOS-OI-1/9/2005

Human cytomegalovirus encodes a highly specific RANTES decoy receptor

Wang, D, Bresnahan, W, and Shenk, T

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2004. 101(47): 16642-16647, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225347400048


46. 44707 OI-LS-313; SCIFINDER-OI-1/5/2005

Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines

Haraguchi, Kazuhiro, Takahashi, Haruhiko, Tanaka, Hiromichi, Hayakawa, Hiroyuki, Ashida, Noriyuki, Nitanda, Takao, and Baba, Masanori

Bioorganic & Medicinal Chemistry 2004. 12(20): 5309-5316


47. 44708 OI-LS-313; WOS-OI-1/9/2005

Screening of antibacterial and antifungal activities of ten medicinal plants from Ghana

Hoffman, BR, DelasAlas, H, Blanco, K, Wiederhold, N, Lewis, RE, and Williams, L

PHARMACEUTICAL BIOLOGY 2004. 42(1): 13-17, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225492600003


48. 44709 OI-LS-313; SCIFINDER-OI-1/5/2005

Suppression of hepatitis C virus replicon by TGF-b

Murata, Takayuki, Ohshima, Takayuki, Yamaji, Masashi, Hosaka, Masahiro, Miyanari, Yusuke, Hijikata, Makoto, and Shimotohno, Kunitada

Virology 2005. 331(2): 407-417


49. 44710 OI-LS-313; SCIFINDER-OI-1/5/2005

A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR

Sheehy, P, Scallan, M, Kenny-Walsh, E, Shanahan, F, and Fanning, LJ

Journal of Virological Methods 2005. 123(2): 115-124


50. 44711 OI-LS-313; WOS-OI-1/9/2005

Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase

Vanheusden, V, Munier-Lehmann, H, Froeyen, M, Busson, R, Rozenski, J, Herdewijn, P, and Van, Calenbergh S

JOURNAL OF MEDICINAL CHEMISTRY 2004. 47(25): 6187-6194, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225409400010


51. 44712 OI-LS-313; WOS-OI-1/9/2005

Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitors

Sutherland, JJ and Weaver, DF

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN 2004. 18(5): 309-331, 23


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225572900002



52. 44713 OI-LS-313; WOS-OI-1/9/2005

Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability

Nassar, AEF, Kamel, AM, and Clarimont, C

DRUG DISCOVERY TODAY 2004. 9(23): 1020-1028, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225329500007


53. 44714 OI-LS-313; WOS-OI-1/9/2005

Synthesis of trehalose-based compounds and their inhibitory activities against Mycobacterium smegmatis

Wang, J, Elchert, B, Hui, Y, Takemoto, JY, Bensaci, M, Wennergren, J, Chang, H, Rai, R, and Chang, CWT

BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(24): 6397-6413, 17


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225523200007


54. 44715 OI-LS-313; WOS-OI-1/9/2005

Crystallographic and NMR studies of antiinfective tricyclic guanidine alkaloids from the sponge Monanchora unguifera

Hua, HM, Peng, JN, Fronczek, FR, Kelly, M, and Hamann, MT

BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(24): 6461-6464, 4


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225523200012


55. 44716 OI-LS-313; WOS-OI-1/9/2005

Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues

Monga, V, Nayyar, A, Vaitilingam, B, Palde, PB, Jhamb, SS, Kaur, S, Singh, PP, and Jain, R

BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(24): 6465-6472, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225523200013


56. 44717 OI-LS-313; WOS-OI-1/9/2005

Synthesis and study of antibacterial and antifungal activities of novel 2-[[(benzoxazole/benzimidazole-2-yl)sulfanyl] acetylamino]thiazoles

Kaplancikli, ZA, Turan-Zitouni, G, Revial, G, and Guven, K

ARCHIVES OF PHARMACAL RESEARCH 2004. 27(11): 1081-1085, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225443900001


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2019